|
Sciele Pharma, Inc. ... ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, has completed its European Phase III study of PSD502 for the...
|
www.medicalnewstoday.com/articles/123777.php
|
|
|
|
Sciele Pharma, Inc. ... ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, and Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, jointly announced that they have initiated patient enrollment for the Phase III...
|
www.medicalnewstoday.com/articles/87459.php
|
|
|
Plethora Solutions soared 8½p to 24p after the healthcare group announced positive phase III trials results for its treatment for premature ejaculation. Finncap estimates the European and US markets for the product could be worth over $1 billion and notes the group also has cash milestone payments to come from a US deal.
|
business.timesonline.co.uk/tol/business/markets/article...
business.timesonline.co.uk/tol/business/markets/article5110719.ece
|
|
AIM listed, Plethora Solutions has signed an exclusive license to manufacture and market in North America Invicorp, Senetek's plc's patented combination drug treatment for male erectile dysfunction.
|
www.smallcapnews.co.uk/article/Plethora_Solutions_to_ma...
www.smallcapnews.co.uk/article/Plethora_Solutions_to_market_erectile_dysfunction_/1088.aspx
|
|
Plethora Solutions Holdings PLE company news, announcements, releases, reports results & notices ... Latest Plethora Solutions Holdings News Headlines...
|
www.advfn.com/company-news-LSE/Plethora-PLE.html
www.advfn.com/company-news-LSE/Plethora-PLE.html
|
|
PLE Sciele Pharma, Inc. ... We look forward to working with Sciele and to updating our shareholders on progress with licensing PSD502 for premature ejaculation elsewhere in territories outside the USA.” About Plethora Solutions: Plethora is focused on the development and marketing of products for the treatment of...
|
www.advfn.com/news_Sciele-Enters-Into-Exclusive-License...
www.advfn.com/news_Sciele-Enters-Into-Exclusive-License-Agreement-with-Plethora-Solutions-Limited-t_20771655.html
|
|
EU trial cheers Plethora 07/11/2008 ... Plethora Solutions 25/05/2007 ... Cardpoint crashes as Plethora leaps 02/12/2005...
|
www.growthcompany.co.uk/company/PLE/PLE.thtml
|
|
View the Plethora Solutions company profile on LinkedIn. See recent hires and promotions, competitors and how you’re connected to Plethora Solutions. ... Plethora Solutions Holdings plc, through its subsidiaries, engages in the development and sale of drugs and medical devices for the diagnosis, treatment,
|
www.linkedin.com/companies/plethora-solutions
www.linkedin.com/companies/plethora-solutions
|
|
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation 7/29/2009 9:44:44 AM More...
|
www.biospace.com/company_profile.aspx?CompanyId=926520
|
|
